R. Pérez López

Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain

J. Hernández-Boluda, A. Álvarez-Larrán, S. Osorio, 2022, Annals of Hematology.

Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors

N. de Las Heras, A. Jiménez-Velasco, A. Angona, 2023, Cancers.

Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice

M. Ramírez, A. Rosell, F. Sánchez-Guijo, 2021, Blood Cancer Journal.